Thalys Medical Technology Group Corporation shareholder Shanghai Angze plans to reduce its shareholding by no more than 3%.

date
21:44 22/01/2025
avatar
GMT Eight
Sail Medical (603716.SH) announced that its shareholder, Shanghai Angze, plans to increase its holdings by no more than 1% of the company's total shares through secondary market transactions from February 24 to 2...
Thalys Medical Technology Group Corporation (603716.SH) announced that its shareholder, Shanghai Angze, plans to reduce its holdings by a total of no more than 5.7296 million shares from February 24, 2025 to May 23, 2025, which is not more than 3% of the total share capital of the company.